[1] Petersen R C, Smith G E, Waring S C, et al. Mild cognitive impairment:clinical characterization and outcome[J]. Arch Neurol, 1999,56(3):303-308. [2] Vlooswijk M C, Jansen J F,de Krom M C, et al. Functional MRI in chronic epilepsy:associations with cognitive impairment[J]. Lancet Neurol, 2010, 9(10):7018-7022. [3] Corder E H, Saunders A M, Strittmatter W J,et al. Gene dose of apolipoprotein E type 4 allele and the risk of Alzheimer's disease in late onset families[J].Science,1993, 261(5123):921-923. [4] Amercian Psychiatric Association. The diagnosic and statisitical manual of menual of mental disorders(DSM-4)[M].Arlington:APA,2008:47. [5] Folstein M F,Folstein S E,Mchugh P R."Mini-mental state":a practical method for grading the cognitive state of patients for the clinician[J].J Psychiatr Res,1975,12(3):189-198 [6] Lawton M P,Brody M P.Assesment of older people:self-maintaining and instrumental activities of daily living[J].Gerontologist,1969,9(3):179-186. [7] Jack C R Jr, Shiung M M, Weigand S D, et al. Brain atrophy rates predict subsequent clinical conversion in normal elderly and amnestic MCI[J]. Neurology, 2005,65(8):1227-1231. [8] Mariani E, Monastero R, Ercolani S, et al. Vascular risk factors in mild cognitive impairment subtypes. Findings from the ReGAl project[J]. Dement Geriatr Cogn Disord, 2007,24(6):448-456. [9] Cherbuin N, Leach L S, Christensen H, et al. Neuroimaging and ApoE genotype:a systematic qualitative review[J]. Dement Geriatr Cogn Disord, 2007, 24(5):348-362. [10] Portet F,Ousset P J,Visser P J,et al.Mild cognitive impairment (MCI) in medical practice:acritical review of the concept and new diagnostic procedure.Report of the MCI working Group of the European Consortium on Alzheimeris DiSEASE[J].J Neurol Neurosurg Psychiatry,2006,77(6):714-718. [11] Dubois B,Feldman H H,Jacova C,et al.Research criteria for the diagnosis of Alzheimer's disease:revising the NINCDS-ADRDA criteria[J].Lancet Neurol,2007,6(8):734-746. [12] Rémy F, Mirrashed F, Campbell B, et al. Verbal episodic memory impairment in Alzheimer's disease:a combined structural and functional MRI study. Neuroimage, 2005,25(1):253-266. [13] Granziera C,Hadjikhani N,Arzy S,et al.In-vivo magnetic resonance imaging of the structuctural core of the Papez circuit in humans[J].Neuroreport,2011,22(5):227-231. [14] Pereira J B, Cavallin L. Spulber G. et al. Influence of age, disease onset and ApoE4 on visual medial temporal lobe atrophy cut-offs[J].Intern Medi. 2014, 275(3); 317-330. |